Effects of benazepril alone or in combination with Valsartan on heart failure in 6 months and 2 years of treatment

JIN Heng,WU Hong-ping,HUA Shou-ming,LIU Zhi-hua
DOI: https://doi.org/10.3969/j.issn.1007-4368.2006.10.020
2006-01-01
Abstract:Objective: To explore the effects of benazepril alone or in combination with valsartan on chronic heart failure with different cause and different NYHA(New York Heart Association) heart function classes in six months and two years. Methods:Sixtyone patients with chronic heart failure were encrolled. The patients were randomly assigned to benazepril group (30 patients) or combination treatment group (31 patients) in addition to standard therapy for a total six months. Plasma level of Norepinephrine(NE) was measured by enzyme-linked immunosorbent assay (ELISA). AngiotensinⅡ(AngⅡ)and Aldosterone(ALD)were measured by radioimmunoassay,doppler echocardiography was performed to measure the parameters of left ventricular function before and 6 months after treatment. Results:Six months and two years after treatment with benazepril in addition to standard therapy, the plasma level of NE was significantly decreased and LVEF was significantly increased(P < 0.01), but the plasma levels of AngⅡand ALD were not changed significantly.After six months and two years of treatment with benazepril in combination with valsartan in addition to standard therapy, the plasma levels of NE and ALD were significantly decreased (P < 0.01) and LVEF was significantly increased (P < 0.01), but the plasma level of AngⅡwaw not changed obviously. Conclusion: Benazepril in combination with valsartan could enhance LVEF (P < 0.01) and reduce the plasma level of NE,AngⅡ,ALD (P < 0.05-0.01) more effectively.Benazepril in combination with valsartan could reduce the rate of hospitalization more effectively(P < 0.05=.
What problem does this paper attempt to address?